Table 1 Baseline characteristics of study subjects
| Â | HIV-/TB | HIV+/TB | HC | BD |
|---|---|---|---|---|
| Â | n = 59 | n = 36 | n = 17 | n = 46 |
Age (years) | 23 (20–29) | 29 (24–34) | 25 (21–35) | 26 (20–37) |
Sex | Â | Â | Â | Â |
   Female | 31 | 22 | 12 | 11 |
   Male | 28 | 14 | 5 | 35 |
BCG vaccination scar (%) | 7 | 8 | 18 | 7 |
Family member treated for TB (%) | 25 | 36 | 100 | 0 |
X-ray | n = 53 | n = 33 | Â | Â |
   Normal (%) | 0 | 3 |  |  |
   Minimal TB (%) | 21 | 36 |  |  |
   Moderately advanced TB (%) | 49 | 49 |  |  |
   Far advanced TB (%) | 30 | 12* |  |  |
Sedimentation rate (mm/h) | 68 (47–80) | 83 (70–98)* |  |  |
Body mass index (kg/m 2 ) | 16.3 (15.5–18.4) | 16.4 (14.7–18.1) |  |  |
Estimated weight loss (kg) | 5.0 (3.0–8.0) | 6.0 (3.3–9.3) |  |  |
Temperature (°C) | 37.7 (37.2–38.3) | 37.9 (37.3–38.5) |  |  |
Fever (%) | 90 | 100 | Â | Â |
Fever (weeks) | 8.0 (4.0–12.0) | 8.4 (4.0–12.0) |  |  |
Cough (weeks) | 10.0 (4.0–16.0) | 8.0 (4.0–13.0) |  |  |
Haemoptysis (%) | 27 | 27 | Â | Â |
Haemoptysis (weeks) | 0.0 (0.0–0.3) | 0.0 (0.0–0.2) |  |  |